Search Results
106 results
Your search is now limited to «Clinical Trials» expert search. 03/22/2019 09:26
The phase I multicentric international prospective trial TIPS (Thrombolysis in Pediatric Stroke) was prematurely stopped because of poor enrollment.
More from
Conatus announces top-line results from ENCORE-NF phase 2b clinical trial in NASH fibrosis.
More from Pharmaceutical Business Review:
Business Wire 03/21/2019 06:30
This Phase 2 trial is being conducted in Japan as a precursor to Phase 3 registration trials in that country.
More from Business Wire:
PR Newswire 03/20/2019 19:20
Preclinical studies have confirmed IBI306's mechanism of action.
More from PR Newswire:
GlobeNewswire 03/20/2019 13:00
The excellent results of this preclinical study further prove the safety of firibastat administration, bringing us closer to the launch of our upcoming Phase 3 clinical trial for resistant hypertension that we hope to launch in the second half of 2019.
More from GlobeNewswire: 03/19/2019 11:57
Apart from PB2452, the company has a candidate – PB1046 – which is being evaluated in a phase IIb study for the treatment of pulmonary arterial hypertension (“PAH.
More from 03/18/2019 13:50
Resverlogix also advances its Fabry Disease indication data and planning CALGARY, Alberta, March 18, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. ('Resverlogix' or the 'Company') (TSX: RVX) today announced the advancement of a $2.9 million project led by academic collaborators at Quebec Heart and Lung Institute, Laval University, to research the clinical potential of its lead drug apabetalone as a potential therapy for pulmonary arterial hypertension ('PAH'); key aspects of this phase 2 clinical study will be the assessment of safety and efficacy in this patient population.
More from
Daiichi Sankyo (Japan) 03/18/2019 11:00
More than 100,000 patients worldwide are expected to participate in EDOSURE studies, the goal of which is to generate new clinical and real-world data regarding its use in AF and VTE populations, providing physicians and patients worldwide with greater treatment confidence.
Stem Cells Portal 03/18/2019 07:22
Overall, these studies highlight umbilical cord MSCs as an exciting source for allogeneic MSC‐based therapy for osteoarthritis [4] (see the SCTM article here and more information on the author, named the STEM CELLS Translational Medicine Young Investigator ...
More from Stem Cells Portal:
Allergan - CEO Blog 03/14/2019 07:54
Topline Phase 3 efficacy and safety results from the ongoing studies will also be presented at a congress later this year.
More from Allergan - CEO Blog:
Preliminary data from preclinical and clinical studies of pulmonary hypertension and heart failure patients provide a reason to believe that levosimendan may provide important benefits for PH-HFpEF patients.
More from Global Banking & Finance Review:
Lancet 02/28/2019 19:22
Although intensive blood pressure lowering is safe, the observed reduction in intracranial haemorrhage did not lead to improved clinical outcome compared with guideline treatment. These results might not support a major shift towards this treatment being applied in those receiving alteplase for mild-to-moderate acute ischaemic stroke. Further research is required to define the underlying mechanisms of benefit and harm resulting from early intensive blood pressure lowering in this patient group.
Benzinga 02/25/2019 12:00
The study will compare single oral doses of the MR firibastat tablets to the immediate release firibastat capsules that were utilized in the recently-completed Phase 2b study of firibastat in hypertension.
More from Benzinga:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications